Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT06238479

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 28 locations
View Trial Details
Active, not recruiting

SCOOT: Sample Collection for DART

NCT05368298

Conditions
Disease, Lung Cancer, Lung Diseases, +8 more
Locations
  • Lung Health Check: Oxford - Churchill Hospital, OUH Oxford, Oxfordshire, United Kingdom
  • Lung Health Check Centre: Royal Sussex Brighton, United Kingdom
  • Lung Health Check Centre: North Bristol Bristol, United Kingdom
  • Lung Health Check Centre: Gateshead Gateshead, United Kingdom
View Trial Details
Active, not recruiting

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

NCT06898957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Active, not recruiting

MYLUNG Consortium Study Protocol 2

NCT05644808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Woodlands Medical Specialists, PA Pensacola, Florida, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 18 locations
View Trial Details
Active, not recruiting

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT05096663

Conditions
Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations
  • Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 350 locations
View Trial Details

Related conditions